Abstract
In this article, the composition and technology of combined eye drops were developed, including taurine as an anti-cataract agent and betaxolol hydrochloride as an anti-glaucoma agent. Butanol, toluene, isopropyl ether, chloroform, ammonia 25%, ethyl alcohol in various ratios were used as the mobile phase. However, these solutions and their combinations did not allow us to determine a system that makes it possible to register both active components simultaneously. Therefore, it was decided to select two thin layer chromatography systems, one of which made it possible to determine taurine, and the other betaxolol hydrochloride
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
